Guillain-Barré syndrome and catecholamine therapy. A potential risk for developing takotsubo cardiomyopathy?

Int J Cardiol. 2013 May 25;165(3):e43-4. doi: 10.1016/j.ijcard.2012.10.083. Epub 2012 Nov 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Catecholamines / adverse effects*
  • Female
  • Guillain-Barre Syndrome / diagnosis*
  • Guillain-Barre Syndrome / drug therapy
  • Humans
  • Middle Aged
  • Takotsubo Cardiomyopathy / chemically induced*
  • Takotsubo Cardiomyopathy / diagnosis*

Substances

  • Catecholamines